POLE Exonuclease Mutant Colon Cancer
1 clinical trials · Condition
◉ Watch POLE Exonuclease Mutant Colon Cancer
| Record | Firm | Date |
|---|---|---|
| Avelumab Plus 5-FU Based Chemotherapy as Adjuvant Treatment for Stage 3 MSI-High or POLE Mutant Colon Cancer (NCT03827044) | Royal Marsden NHS Foundation Trust | 2018-08-31 |
Track POLE Exonuclease Mutant Colon Cancer automatically
Every clearance here is in the API, with alerts when new ones post.